Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase

Clinical trial NCT00630747 · COMPLETED

Trial details

NCT number: NCT00630747
Sponsor: Shire
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hunter Syndrome Mucopolysaccharidosis II (MPS II)

Start date: 2004-09-13
Primary completion: 2008-01-31
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.